These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25212220)

  • 1. Krüppel-like factor 6 interferes with cellular transformation induced by the H-ras oncogene.
    Trucco LD; Andreoli V; Núñez NG; Maccioni M; Bocco JL
    FASEB J; 2014 Dec; 28(12):5262-76. PubMed ID: 25212220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
    Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
    Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
    J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
    Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
    Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells.
    Gehrau RC; D'Astolfo DS; Andreoli V; Bocco JL; Koritschoner NP
    Mutat Res; 2011 Feb; 707(1-2):15-23. PubMed ID: 21147133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
    Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
    Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.
    Mukai S; Hiyama T; Tanaka S; Yoshihara M; Arihiro K; Chayama K
    World J Gastroenterol; 2007 Aug; 13(29):3932-8. PubMed ID: 17663506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
    DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
    Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
    Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P
    Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kruppel-like factor 6 (KLF6) affects the promoter activity of the alpha1-proteinase inhibitor gene.
    Chiambaretta F; Nakamura H; De Graeve F; Sakai H; Marceau G; Maruyama Y; Rigal D; Dastugue B; Sugar J; Yue BY; Sapin V
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):582-90. PubMed ID: 16431954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
    Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
    Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6.
    Kimmelman AC; Qiao RF; Narla G; Banno A; Lau N; Bos PD; Nuñez Rodriguez N; Liang BC; Guha A; Martignetti JA; Friedman SL; Chan AM
    Oncogene; 2004 Jun; 23(29):5077-83. PubMed ID: 15064720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
    Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.